HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Vaxart, Inc. (VXRT)
5.34  -0.33  (-5.82%) 10-20 18:15
Open: 5.6 High: 5.76
Pre.close: 5.67 Low: 5.18
Volume: 8,173,652 Ave vol: 20,344,221
52w High: 17.49 52w Low: 0.27
MA(50): 6.654 MA(200): 6.06
EPS: -0.44 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: https://vaxart.com/
Market Cap (M): 585
Shares Out (M): 109
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines. The company is headquartered in South San Francisco, California and currently employs 28 full-time employees. The firm has three product candidates in clinical development that address viral infections that have limited therapeutic options. Its products include vapendavir, an oral treatment for human rhinovirus (HRV) upper respiratory infections in moderate-to-severe asthmatics in Phase IIb SPIRITUS trial; BTA585, an oral fusion (F) protein inhibitor in Phase II development for the treatment and prevention of respiratory syncytial virus (RSV) infections, and BTA074, a topical antiviral treatment in Phase II development for condyloma caused by human papillomavirus Types 6 and 11. The company has preclinical RSV non-fusion inhibitor program. The company has focused its research and drug development capabilities on discovering and developing small molecule compounds that can prevent or treat infectious diseases.
Technical analysis
Overall: Underperform
MA: Bullish MACD: Bearish
KDJ: Bullish RSI: Bearish
Target 1: 9.12 Target 2: 11.01
Resist 1: 7.81 Resist 2: 9.43
Support 1: 5.18 Support 2: 4.31
Company key metrics
Revenue per Share: 0.4572
Net Income per Share: -0.8644
Cash per Share: 0.6271
Book Value per Share: 0.6005
Price to Sales: 1.5966
Price to Book Value: 1.2157
Earnings Yield: -1.1841
Dividend Yield: 0
Debt to Equity: 1.8592
Debt to Assets: 0.6502
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Outperform
Stock Charts

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.